Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £195.03m
BMD Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead 2vt Share Chart

Offer for Subscription - Update

24 Nov 2017 13:27

RNS Number : 4948X
Baronsmead Second Venture Trust PLC
24 November 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA.

BARONSMEAD SECOND VENTURE TRUST PLC

24 November 2017

Offer for Subscription - Update

On 4 October 2017, Baronsmead Second Venture Trust plc (the "Company") published a prospectus (the "Prospectus") in relation to an offer for subscription to raise up to £24 million (the "Offer").

The Board is pleased to announce that as at close of business on 23 November 2017 the Company had raised gross proceeds of over £21 million pursuant to the Offer. The Offer remains open to Existing Shareholders and new investors and there remains approximately £3 million of New Shares available for allotment.

Subscriptions will be processed by the Receiving Agent on a "first come, first served" basis. Existing Shareholders and new investors who wish to participate in the Offer should return a completed Subscription Form to the Receiving Agent, as set out in the Prospectus, as soon as possible.

It is expected that the final allotment of New Shares pursuant to the Offer will take place on or around 20 December 2017 or earlier if the Offer becomes fully subscribed.

Definitions

Terms defined in the Prospectus have the same meanings in this announcement unless the context requires otherwise.

Further information

For further information please contact.

Michael Probin - VCT investor relations

Livingbridge VC LLP

020 7506 5796

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUSUORBSAAUAA
Date   Source Headline
13th Sep 20237:00 amRNSTransaction in Own Shares - Replacement
12th Sep 20235:28 pmRNSTransaction in Own Shares
5th Sep 202311:00 amRNSIntention to Fundraise
4th Aug 20234:00 pmRNSNet Asset Value(s)
1st Aug 20231:54 pmRNSTotal Voting Rights
27th Jul 20234:11 pmRNSTransaction in Own Shares
24th Jul 20232:00 pmRNSNet Asset Value(s)
3rd Jul 202311:25 amRNSTotal Voting Rights
20th Jun 20233:40 pmRNSTransaction in Own Shares
13th Jun 20237:00 amRNSHalf-yearly Report
6th Jun 20235:30 pmRNSNet Asset Value(s)
12th May 20237:00 amRNSCompliance with the Market Abuse Regulation
5th May 20235:30 pmRNSNet Asset Value(s)
4th May 20231:00 pmRNSNet Asset Value(s)
2nd May 202312:52 pmRNSTotal Voting Rights
5th Apr 20236:30 pmRNSTransaction in Own Shares
3rd Apr 20235:26 pmRNSTotal Voting Rights
3rd Apr 20233:49 pmRNSAllotment of Shares
3rd Apr 202311:11 amRNSTotal Voting Rights
30th Mar 202312:00 pmRNSNet Asset Value(s)
27th Mar 20235:23 pmRNSUpdate on Fundraising
14th Mar 20234:28 pmRNSAllotment of Shares
13th Mar 20235:44 pmRNSDirector/PDMR Shareholding
13th Mar 20235:43 pmRNSDirector/PDMR Shareholding
9th Mar 20236:25 pmRNSTransaction in Own Shares
9th Mar 20233:17 pmRNSUpdate on Fundraising
6th Mar 20234:45 pmRNSNet Asset Value(s)
1st Mar 20232:23 pmRNSTotal Voting Rights
24th Feb 20235:20 pmRNSUpdate on Fundraising
17th Feb 20236:16 pmRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSTransaction in Own Shares
6th Feb 20235:00 pmRNSNet Asset Value(s)
1st Feb 20233:58 pmRNSDirector/PDMR Shareholding
1st Feb 20233:56 pmRNSResult of AGM
30th Jan 20235:38 pmRNSDirector/PDMR Shareholding
30th Jan 20235:36 pmRNSDirector/PDMR Shareholding
30th Jan 20233:05 pmRNSAllotment of Shares
27th Jan 202311:30 amRNSNet Asset Value(s)
3rd Jan 20234:50 pmRNSTotal Voting Rights
29th Dec 20224:56 pmRNSTransaction in Own Shares
16th Dec 202212:47 pmRNSPublication of a Prospectus
12th Dec 20224:45 pmRNSTransaction in Own Shares
6th Dec 20225:30 pmRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSAnnual Financial Report
7th Nov 202211:30 amRNSNet Asset Value(s)
1st Nov 202211:21 amRNSTotal Voting Rights
14th Oct 20226:16 pmRNSTransaction in Own Shares- Correction
14th Oct 20224:45 pmRNSNet Asset Value(s)
4th Oct 202211:57 amRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.